Regulation And Legal
Zydus Formycon FYB206 Keytruda Biosimilar USFDA Review
USFDA accepted BLA for FYB206, the first publicly announced Keytruda biosimilar application for review.
FYB206 developed without Phase III efficacy trial under agreed USFDA pathway, accelerating devel
